Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Development of a risk-based environmental management tool for drilling discharges. Summary of a four-year project.

Singsaas I, Rye H, Frost TK, Smit MG, Garpestad E, Skare I, Bakke K, Veiga LF, Buffagni M, Follum OA, Johnsen S, Moltu UE, Reed M.

Integr Environ Assess Manag. 2008 Apr;4(2):171-6.

PMID:
18494116
2.

Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells.

McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Skare IB, Lynch RD, Schneeberger EE.

J Cell Sci. 2000 Oct;113 Pt 19:3387-98.

3.

Speciation of mercury excreted in feces from individuals with amalgam fillings.

Engqvist A, Colmsjö A, Skare I.

Arch Environ Health. 1998 May-Jun;53(3):205-13.

PMID:
9814717
4.

The absorption, blood levels, and excretion of mercury after a single dose of mercury vapor in humans.

Sandborgh-Englund G, Elinder CG, Johanson G, Lind B, Skare I, Ekstrand J.

Toxicol Appl Pharmacol. 1998 May;150(1):146-53.

PMID:
9630463
5.

Occludin is a functional component of the tight junction.

McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE.

J Cell Sci. 1996 Sep;109 ( Pt 9):2287-98.

6.

Human exposure to mercury and silver released from dental amalgam restorations.

Skare I, Engqvist A.

Arch Environ Health. 1994 Sep-Oct;49(5):384-94.

PMID:
7944571
7.

[Amalgam fillings--a considerable source of exposure to heavy metals].

Skare I, Engqvist A.

Lakartidningen. 1992 Apr 8;89(15):1299-301. Swedish. No abstract available.

PMID:
1579001
8.

A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84.

Skinner M, Harding J, Skare I, Jones LA, Cohen AS, Milunsky A, Skare J.

Ophthalmology. 1992 Apr;99(4):503-8.

PMID:
1350083
9.

A new transthyretin variant from a patient with familial amyloidotic polyneuropathy has asparagine substituted for histidine at position 90.

Skare JC, Milunsky JM, Milunsky A, Skare IB, Cohen AS, Skinner M.

Clin Genet. 1991 Jan;39(1):6-12.

PMID:
1997217
10.

Mercury exposure of different origins among dentists and dental nurses.

Skare I, Bergström T, Engqvist A, Weiner JA.

Scand J Work Environ Health. 1990 Oct;16(5):340-7.

11.
12.

A new mutation causing familial amyloidotic polyneuropathy.

Skare JC, Saraiva MJ, Alves IL, Skare IB, Milunsky A, Cohen AS, Skinner M.

Biochem Biophys Res Commun. 1989 Nov 15;164(3):1240-6.

PMID:
2590199
13.

[Exposure to mercury among dental health care personnel in and around Stockholm].

Skare I.

Tandlakartidningen. 1988 Dec 15;80(24):1432-7. Swedish. No abstract available.

PMID:
3270474
14.
15.
16.

[Automatic determination of mercury in biological samples].

Lindstedt G, Skare I.

Nord Hyg Tidskr. 1971;52(1):45-7. Swedish. No abstract available.

PMID:
5565697
17.

Generation and determination of ozone in low concentrations.

Skare I.

Air Water Pollut. 1965 Oct;9(10):601-4. No abstract available.

PMID:
5837724

Supplemental Content

Support Center